<?xml version="1.0" encoding="UTF-8"?>
<p>Impaired insulin or insulin-like growth factor-1 (IGF-1) signaling is associated with AD. It leads to hyperphosphorylation of the tau protein, mitochondrial dysfunction, oxidative stress and necrosis, and contributes to cognitive impairment [
 <xref rid="B113-brainsci-10-00964" ref-type="bibr">113</xref>,
 <xref rid="B114-brainsci-10-00964" ref-type="bibr">114</xref>,
 <xref rid="B115-brainsci-10-00964" ref-type="bibr">115</xref>]. Curcumin significantly improved cognitive function by improving the IGF-1 level in the intracerebroventricular (ICV)-streptozotocin (STZ) model of sporadic AD [
 <xref rid="B116-brainsci-10-00964" ref-type="bibr">116</xref>]. It also suppressed IL-1 and glial fibrillary acidic protein, reduced oxidative damage and plaque burden and decreased the amount of insoluble amyloid [
 <xref rid="B26-brainsci-10-00964" ref-type="bibr">26</xref>]. Another experimental study showed that curcumin treatment restored learning and memory functions in the STZ model of AD by reducing the oxidative stress, enhancing ChAT activity and restoring insulin receptor protein [
 <xref rid="B117-brainsci-10-00964" ref-type="bibr">117</xref>,
 <xref rid="B118-brainsci-10-00964" ref-type="bibr">118</xref>].
</p>
